Merck had a successful fiscal 2020, a year that was marked by the Covid-19 pandemic. The company increased its sales, expanded its EBITDA pre margin and met all the financial targets it had set for itself.
Fiscal 2020:
Sales increase by 8.6% to € 17.5 billion; EBITDA pre jumps 18.6% to € 5.2 billion; EBITDA pre margin rises to 29.7%; earnings per share pre grow 20.5% to € 6.70
Performance Materials renamed Electronics with immediate effect
Dividend proposal of € 1.40 per share
Forecast for fiscal 2021:
Strong organic sales growth expected
Organic EBITDA pre growth in the high single-digit to low teens percentage range